Similarly, Ilie et al. evaluate the levels of PD-L1 in CTCs and WBCs (white blood cells) and point out the potential of CTC assessment as a real-time biopsy to detect PD-L1 expression in patients with NSCLC (105). The gene discussed is CD274; the disease is non-small cell lung carcinoma.